Comment on CMS-2026-1255-0001

Summary: The American Osteopathic Association and 16 other osteopathic medical organizations support the proposed rule to streamline prior authorization for drugs through technical standards and APIs. They advocate for further improvements, including more specific reporting metrics, shorter decision timeframes for non-drug requests, and policies that limit prior authorization to high-risk clinical scenarios.